

















A growing body of literature implicates the intracellular 
post-translational carbohydrate modification O-GlcNAc 
in type II diabetic insulin resistance [2, 4, 12, 13]. O-
GlcNAc levels are responsive to increased nutrient flux 
through the hexosamine biosynthetic pathway. 
Hyperglycemia in type II diabetes thus drives abnormal 
elevation of O-GlcNAc [1]. Mice over-expressing OGT 
(the enzyme which catalyzes addition of O-GlcNAc to 
proteins) display insulin resistant type II diabetic 
phenotypes [9]. However, OGT appears to be 
fundamentally essential for mammalian cellular life 
[10], limiting the potential to test models of O-GlcNAc 
involvement in insulin resistance/signaling by OGT 
knock-out studies in mammals.  
 
C. elegans has a conserved insulin-like signaling 
pathway which regulates phenotypes including life 
span, dauer larvae formation, stress responses, and 
macronutrient storage. Additionally, there is a high 
level of conservation between C. elegans and 
mammalian OGT and OGA (enzyme that removes O-
GlcNAc) [3, 8]. In contrast to mammalian systems, C. 
elegans with OGT and OGA null mutant alleles are 
viable and fertile [5, 3]. Thus, C. elegans is potentially 
amenable to genetic testing of interactions between         
O-GlcNAc cycling and insulin signaling/phenotypes. In 
C. elegans, attenuation of insulin-like signaling induces 
a so-called dauer larval stage. An insulin receptor-like 
mutant allele (daf-2) with reduced signaling induces 
dauer formation, and this was enhanced by an OGA null 
mutant which elevated O-GlcNAc [3], and inhibited by 
an OGT null mutant which reduced O-GlcNAc levels 
[5].  Those results suggested that  O-GlcNAc negatively 
regulates insulin-like signaling in the context of dauer 
formation. This is reminiscent of the model in which 
increased hexosamine  flux and elevated O-GlcNAc  are  
 
 
















linked to type II diabetic insulin resistance (reduced 
insulin signaling) in mammals. Similar regulation of 
entry into the dauer state induced by a synthetic 
pheromone called daumone was observed in C. elegans 
with OGT and OGA inactivating mutant alleles [6]. 
Additionally, C. elegans OGA mutants display macro-
nutrient storage phenotypes that parallel those of 
mammalian diabetic states [3]. 
  
In this issue, Rahman et al. [11] extend genetic studies 
of OGT and OGA inactivation in C. elegans to provide 
important information about specificity of O-GlcNAc 
regulation of insulin-like phenotypes and the steps in 
insulin-like signaling that are regulated by O-GlcNAc. 
Attenuation of insulin-like signaling extends lifespan in 
C. elegans. Rahman et al. find that OGA inactivating 
mutants increase life span, while OGT inactivating 
mutants decrease life span. Similar observations were 
previously reported [7] and will be discussed in more 
detail below. The genetic studies of O-GlcNAc cycling 
linked to longevity indicate elevation of O-GlcNAc 
inhibits, while decreased O-GlcNAc increases insulin-
like signaling, again consistent with models of elevated 
O-GlcNAc linked to mammalian insulin resistance, and 
highlighting the potential significance of C. elegans as a 
genetic model to continue examining how O-GlcNAc 
cycling impinges on insulin signaling. Indeed, Rahman 
et al. go on to show the long lived OGA null mutant did 
not further extend long lived phenotypes of conserved 
insulin   signaling   homologue  mutants  of  the   insulin 
  receptor (daf-2), and downstream signaling compo-
nents PI 3-kinase (AGE-1), and AKT (SGK-1), 
consistent with O-GlcNAc regulation acting in this 
insulin-like pathway. The daf-2 longevity phenotype is 
dependent on daf-16, a foxO homologue transcription 
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extension phenotype is also dependent on daf-16. 
However, they observe that both OGA and OGT null 
mutants increased daf-16 nuclear localization. This 
result combined with the observation that OGA and 
OGT null mutants have opposite affects on longevity, 
suggest that O-GlcNAc regulation of insulin-like 
signaling connected to longevity acts downstream of 
daf-16.  
 
Rahman et al. also examined OGT and OGA null 
mutant interaction with other known insulin-like 
signaling dependent phenotypes and found that the 
OGA mutant was resistant to oxidative stress, while the 
OGT mutant reduced stress resistance in a daf-2 mutant 
background. This is reminiscent of the previously 
reported affects of OGT and OGA null mutants on UV 
stress tolerance [7]. Rahman et al. go on to show that 
the OGA null mutant does not alter known daf-2 
(insulin receptor mutant) phenotypes of increased 
thermal tolerance, delayed developmental timing 
defects, or reduced fecundity. Since these phenotypes 
are dependent on daf-16, the results further suggest that 
O-GlcNAc regulation is occurring downstream of daf-
16. Thus, the results begin to specifically assign O-
GlcNAc regulation to only a subset of insulin-like 
signaling phenotypes. Specificity of O-GlcNAc 
regulation of stress tolerance and not thermal tolerance 
is supported by their observation that OGA mutants 
selectively alter transcription profiles associated with 
oxidative stress [11]. 
 
The previous reports on O-GlcNAc regulation of 
insulin-like signaling in C. elegans and the extension of 
that knowledge by Rahman et al. in this issue establish 
an important model system for study of O-GlcNAc 
regulation of insulin signaling which will help unravel 
O-GlcNAc links to mammalian insulin resistance. It 
should be noted that there are a few minor disparities 
between the Rahman et al. studies [11] and a previous 
report [7]. Both reports show that OGT null mutants 
decrease longevity in both wild type and daf-2 long 
living backgrounds, indicating that O-GlcNAc 
negatively regulates insulin-like signaling in the context 
of longevity. Both reports find that OGA null mutants 
can lead to a life extension phenotype, but under 
somewhat different circumstances. Rahman et al. find 
that the OGA null mutant extends lifespan in a wild 
type background, but not in daf-2, age-1, or sgk-1 long 
living mutant backgrounds. Love et al. report no affect 
of OGA null mutant on life span in a wild type 
background, but an extension of life span in the daf-2 
mutant. As mentioned, daf-16 is required for the daf-2 
longevity phenotype. Rahman et al. find that the 
increased longevity of the OGA null mutants are 
dependent on daf-16, whereas Love et al. find that OGA 
null mutant extension of lifespan in the daf-2 
background is not dependent on daf-16.Both reports 
show that OGT null mutants have aberrant constitutive 
nuclear accumulation of daf-16, but Rahman et al. find 
that the OGA null mutant also has this phenotype. 
Distinctions between OGA null mutant affects being 
dependent on daf-16 and altering daf-16 nuclear 
localization may be important to reconcile, as those 
results help define where in the insulin-like signaling 
pathway that O-GlcNAc regulation occurs.  Differences 
in background strain, back crossing, and temperatures 
used may possibly contribute to these disparities and 
RNAi experiments as well as additional ogt and oga 
alleles should be able to resolve these issues.  
 
Nevertheless, the stage is set now to go further in 
defining specific mechanisms of how O-GlcNAc 
regulates insulin-like phenotypes and how modification 
of specific proteins influence their function in insulin-
like signaling. Love et  al. previously began to approach 
these questions by asking where O-GlcNAc marks 
chromatin and found a bias at promoters that regulate 
carbohydrate metabolism and chromatin remodeling [7]. 
Rahman et al. begin to approach this question using 
proteomics to identify changes in expression of putative 
O-GlcNAc modified proteins in response to the OGA 
null mutant, and find interestingly that a high 
percentage of proteins identified are regulated by 
insulin signaling and/or contribute to insulin-like 
signaling phenotypes. These observations provide a 
foundation for future functional studies in which the 
lifespan of a worm may help us to understand type II 
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